InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Humphries William D., Director. Officer active across 3 companies, notably STRATA Skin Sciences, Inc.. In total, 7 reports have been logged. Total volume traded: €48k. The latest transaction was disclosed on 25 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
3,356 shares
Common Stock
SEC:0001209191-22-034585:0·
€26,69016,950 shares@ €1.57460.36% mcap55.7% of flow
SSKN Common Stock
SEC:0001051514-22-000035:0·
Ideal exit: 20 Dec 2022 (T+270)
€21,24814,783 shares@ €1.43740.29% mcap44.3% of flow
SSKN Common Stock
SEC:0001051514-22-000033:0·
Ideal exit: 19 Dec 2022 (T+270)
€3,00322,727 shares@ €0.13210.0041% mcap100.0% of flow
Common Stock
SEC:0001209191-22-002893·
€3,00322,727 shares@ €0.13210.0041% mcap50.0% of flow
Common Stock
SEC:0001209191-22-002893:0·
020,000 shares0
SSKN Common Stock
SEC:0001051514-21-000034·
020,000 shares0
SSKN Common Stock
SEC:0001051514-21-000034:0·
7 of 7 declarations
About Humphries William D.
William D. Humphries serves as a Director at Strata Skin Sciences, Inc., Clearside Biomedical, Inc., and Aclaris Therapeutics, Inc. In these roles, he participates in the governance and strategy of the companies, bringing his expertise in the life sciences field. William D. Humphries is committed to ensuring regulatory compliance and supporting the growth of these companies through informed and strategic decision-making.
